An assessment of the ocular safety of inactive excipients following sub-tenon injection in rabbits

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 2, 2008, Pages 206-216

  Younis, Husam S ^a   Shawer, Mohannad ^a   Palacio, Kimberly ^a   Gukasyan, Hovhannes J ^a   Stevens, Greg J ^a   Evering, Winston ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; BENZYL ALCOHOL; CARBOXYMETHYLCELLULOSE; CITRATE SODIUM; EXCIPIENT; MACROGOL; METHYLCELLULOSE; POLOXAMER; POLYSORBATE 80; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHEMOSIS; CORNEA OPACITY; DRUG SAFETY; DRUG TOLERABILITY; EYE EDEMA; EYE INFLAMMATION; EYE IRRITATION; FEMALE; HISTIOCYTE; HISTOLOGY; MOLECULAR WEIGHT; NONHUMAN;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCIPIENTS; EYE; FEMALE; INJECTIONS; IRRITANTS; PHARMACEUTICAL PREPARATIONS; RABBITS; SEVERITY OF ILLNESS INDEX;

EID: 41349117458     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0099     Document Type: Article

References (34)

1. Jonas, J.B., Kreissig, I., and Degenring, R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog. Ret. Eye Res. 24:587-611, 2005.
2. Raghava, S., Hammond, M., and Kompella, U.B. Periocular routes for retinal drug delivery. Exp. Opin. Drug Deliv. 1:99-114, 2004.
3. Smerdon, D. Anatomy of the eye and orbit. Curr. Anaesth. Crit. Care 11:286-292, 2000.
4. Mafee, M.F., Karimi, A., Shar, J.D., et al. Anatomy and pathology of the eye: Role of MR imaging and CT. Magn. Res. Imaging Clin. 14:249-270, 2006.
5. Shauly, Y., Miller, B., Lichtig, C., et al. Tenon's capsule: Ultrastructure of collagen fibrils in normals and infantile esotropia. Inv. Oph. Visual Sci. 33:651-656, 1992.
6. Maurice, D.M., and Mishima, S. Ocular pharmacokinetics. In: Sears, M.L., ed. Pharmacology of the Eye. Berlin: Springer-Verlag, 1985:19-116.
7. Ozdek, S., Bahceci, U.A., Gurelik, G., et al. Posterior sub-Tenon and intravitreal triamcinolone acetonide for diabetic macular edema. J. Diab. Compl. 20:246-251, 2006.
8. Thomas, E.R., Wang, J., Ege, E., et al. Intravitreal triamcinolone acetonide concentration after sub-Tenon injection. Am. J Oph. 142:860-861, 2006.
9. Lafranco, D.M., Tran, V.T., Guex-Crosier, Y., et al. Posterior sub-Tenon steroid injections for the treatment of posterior ocular inflammation: Indications, efficacy, and side effects. Graefe's Arch. Clin. Exp. Ophthalmol. 237:289-295, 1999.
10. Ciulla, T.A., Walker, J.D., Fong, D.S., et al. Corticosteroids in posterior segment disease: An update on new delivery systems and indications. Curr. Opin. Ophth. 15:211-220, 2004.
11. Mueller, A.J., Jian, G., Banker, A.S., et al. The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. Am. J. Oph. 125:158-163, 1998.
12. Kumar, C.M., Dodds, C., McLure, H., et al. A comparison of three sub-Tenon's cannulae. Eye 18:873-876, 2004.
13. Hida, T., Chandler, D., Arena, J.E., et al. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am. J. Oph. 101:190-196, 1986.
14. Chetoni, P., Burgalassi, S., Monti, D., et al. Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas. Toxicol. In Vitro 17:497-504, 2003.
15. Takeda, A.L., Colquitt, J.L., Clegg, A.J., et al. Pegaptanib and ranibizumab for neovascular age-related macular degeneration: A systematic review. Br. J. Oph. In press, 2007.
16. Eter, N., Krohne, T.U., and Holz, F.G. New pharmacologic approaches to therapy for age-related macular degeneration. Biodrugs 20:167-179, 2006.
17. Meyer, C.H. (2007). Current treatment approaches in diabetic macular edema. Ophthalmologica 221:118-131, 2007.
18. Hoyng, C.B., Vingerling, J.R., Hooymans, J.M., et al. AG-013958 (VEGFR inhibitor) achieves effective choroidal concentrations with minimal systemic effects in cynomolgus monkeys and humans with age-related macular disease. Association for Research in Vision and Ophthalmology Annual Meeting, Poster #2365, May 2, 2005. Fort Lauderdale, FL.
19. Hayek, S., Scherrer, M., Barthelmes, D., et al. First clinical experience with anecortave acetate (Retaane). Klin. Monatsbl. Augenheilkd. 224:279-281, 2007.
20. Russell, S.R., Hudson, H.L., and Jerdan, J.A. Anecortave acetate for the treatment of exudative age-related macular degeneration - a review of clinical outcomes. Surv. Ophthalmol. 52(Suppl 1):S79-S90, 2007.
21. Toda, J., Fukushima, H., and Kato, S. Injection of triamcinolone acetonide into the posterior sub-Tenon capsule for treatment of diabetic macular edema. Retina 27:764-769, 2007.
22. Chou, A., Hori, S., and Takase, M. Ocular toxicity of beta-blockers and benzalkonium chloride in pigemented rabbits: Electrophysiological and morphological studies. Jpn. J. Oph. 29:13-23, 1985.
23. U.S. Food and Drug Administration, CDER, Office of Generic Drugs. Inactive ingredient search for approved products, 2007. www.access data.fda.gov/scripts/cder/fda/index.cfm
24. Euerby, M.R. High-performance liquid chromatography of benzalkonium chlorides - variation in commercial preparations. J. Clin. Hosp. Pharm. 10:73-77, 1985.
25. Britton, B., Hervey, R., Kasten, K., et al. Intraocular irritation evaluation of benzalkonium chloride in rabbits. Ophthal. Surg. 7:46-55, 1976.
26. El Gawad, A., Ramadan, E.M., and El Helw A.M. Formulation and stability of saluzide eye drops. Pharm. Ind. 49:751-754, 1987.
27. Oza, K.P., and Frank, S.G. Microcrystalline cellulose stabilized emulsions. J. Disper. Sci. Technol. 7:543-561, 1986.
28. Hussain, M.A., Aungst, B.J., Maurin, M.B., et al. Injectable suspensions for prolonged release nalbuphine. Drug Dev. Ind. Pharm. 17:67-76, 1991.
29. Karabit, M.S., Juneskans, O.T., and Lundgren, P. Studies on the evaluation of preservative efficacy II: The determination of antimicrobial characteristics of benzyl alcohol. J. Clin. Hosp. Pharm. 11:281-289, 1986.
30. Shah, A.K., Simons, K.J., and Briggs, C.J. Physical, chemical, and bioavailability studies of parenteral diazepam formulations containing propylene glycol and polyethylene glycol 400. Drug Dev. Ind. Pharm. 17:1635-1654, 1991.
31. Emerson, M.V., and Lauer, A.K. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema. BioDrugs 21:245-257, 2007.
32. Sutter, F.P., and Gillies, M.C. Psuedo-endophthalmitis after intravitreal injection of triamcinolone. Br. J. Oph. 87:972-974, 2003.
33. Morrison, V.L., Koh, H.J., Cheng, L., et al. Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits. Retina 26:339-344, 2006.
34. Sherman, G.J. Preservative system for ophthalmic and contact lens solutions and method for cleaning, dis-infecting, and storing contact lenses. U.S. Patent #5,322,667, 1994.